IT enabled redesign of export procedure for high-value pharmaceutical product under temperature control: the case of drug living lab

  • Authors:
  • Jianwei Liu;Allen Higgins;Yao-Hua Tan

  • Affiliations:
  • Vrije Universiteit Amsterdam, Administration, De Boelelaan, HV Amsterdam, The Netherlands;University College Dublin CITO, Belfield, Ireland;Delft University of Technology, BX Delft, The Netherlands

  • Venue:
  • Proceedings of the 11th Annual International Digital Government Research Conference on Public Administration Online: Challenges and Opportunities
  • Year:
  • 2010

Quantified Score

Hi-index 0.00

Visualization

Abstract

In this paper, we analyze and redesign the export procedure for shipping a high-value pharmaceutical product in a strict temperature-controlled logistics environment (cold chain) from Ireland to the US using the e3-control methodology. The e3-control methodology has been used in this case to support the introduction of a novel cold-chain innovation in a pilot project running in a live 3rd Party Logistics (3PL) environment. The resulting pilot project has attempted to prove the feasibility of providing real-time shipment temperature and location data in international multi-modal supply chains. The pilot is designed to satisfy more stringent control requirements for temperature-sensitive bulk pharmaceutical shipments and thereby enhance drug safety and security. In the meantime, supply chain interactions with various governmental bodies for regulatory clearance and Customs simplification (e.g. FDA and USDA procedures) are considered. The e3-control model-based redesign methodology is demonstrated in this case to be a useful approach to analyzing and redesigning international logistics procedures in reaction to a technological innovation, which facilitates trade security and transparency for both government and businesses.